Landscape Capital Management’s Blueprint Medicines BPMC Stock Holding History

Landscape Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,468	Closed	-$1.6M	–	628
2025 Q2	$1.6M	Buy	+12,468	New	+$1.29M	0.13%	242
2017 Q2	–	Sell	-9,236	Closed	-$369K	–	325
2017 Q1	$369K	Buy	+9,236	New	+$331K	0.04%	361

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Landscape Capital Management's BPMC Position: Q3 2025 in Review

Landscape Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 12,468 shares — an estimated $1.6M sold.

Landscape Capital Management first reported a position in BPMC in Q1 2017 and held it in 2 quarters. The position peaked at $1.6M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Landscape Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Landscape Capital Management sold 12,468 Blueprint Medicines shares in Q3 2025, an estimated $1.6M.
Landscape Capital Management first reported a position in Blueprint Medicines in Q1 2017 and held it in 2 quarters.
Landscape Capital Management's Blueprint Medicines position peaked at $1.6M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Landscape Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.